NASDAQ:CSBR

Champions Oncology Insider Trades

$11.46
+0.11 (+0.97 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.17
Now: $11.46
$11.71
50-Day Range
$10.72
MA: $11.78
$13.75
52-Week Range
$6.80
Now: $11.46
$14.68
Volume16,557 shs
Average Volume32,312 shs
Market Capitalization$153.45 million
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Insider Trades

Champions Oncology (NASDAQ:CSBR) Insider Buying and Selling Activity

Insider Ownership Percentage: 46.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $356,878.05

Insider Buying and Selling by Quarter


Champions Oncology (NASDAQ CSBR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2020Philip P. BreitfeldDirectorSell31,443$11.35$356,878.05  
3/26/2020Daniel Newman MendelsonDirectorBuy1,220$5.91$7,210.2057,546  
3/24/2020Daniel Newman MendelsonDirectorBuy26$5.50$143.0057,526  
3/24/2020Ronnie MorrisCEOSell75$5.25$393.75837,168  
3/20/2020Ronnie MorrisCEOBuy75$4.75$356.25837,243  
3/6/2020Enterprise Associates 14 NewMajor ShareholderSell708,155$6.99$4,950,003.45  
12/19/2018Ronnie MorrisCEOBuy20,000$7.44$148,800.00833,001  
11/6/2018Daniel Newman MendelsonDirectorSell5,000$13.75$68,750.0057,500  
10/1/2018Joel AckermanDirectorSell22,535$17.02$383,545.701,021,731  
9/20/2018Daniel Newman MendelsonDirectorSell8,333$13.02$108,495.6662,500  
3/27/2018Ronnie MorrisCEOBuy4,535$3.59$16,280.651,114,282  
3/22/2018Ronnie MorrisCEOBuy260$3.49$907.401,111,407  
10/21/2016Ronnie MorrisPresidentBuy30,000$1.66$49,800.001,091,347  
10/19/2016Ronnie MorrisPresidentBuy10,000$1.70$17,000.001,081,347  
10/18/2016Joel AckermanCEOBuy2,000$1.70$3,400.001,043,266  
10/14/2016Joel AckermanCEOBuy7,300$1.67$12,191.001,035,466  
10/14/2016Ronnie MorrisPresidentBuy10,305$1.66$17,106.301,061,347  
10/13/2016Ronnie MorrisPresidentBuy29,695$1.67$49,590.651,041,347  
10/10/2016Ronnie MorrisPresidentBuy9,537$1.66$15,831.421,026,347  
10/7/2016Joel AckermanCEOBuy8,202$1.63$13,369.261,027,764  
9/23/2016Joel AckermanCEOBuy33$1.65$54.451,026,764  
9/21/2016Joel AckermanCEOBuy5,000$1.66$8,300.001,022,731  
9/20/2016Ronnie MorrisPresidentBuy3,000$1.58$4,740.001,021,810  
3/11/2015Michael Maurice BrownMajor ShareholderBuy6,250,000$0.40$2,500,000.00  
3/20/2014Daniel Newman MendelsonDirectorBuy100,000$1.08$108,000.00  
3/19/2014Ronnie MorrisPresidentBuy100,000$1.07$107,000.00  
1/28/2013Michael Maurice BrownMajor ShareholderBuy7,000,000$0.50$3,500,000.00  
1/28/2013Ronnie MorrisPresidentBuy500,000$0.50$250,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.